Congenital Deafness – Panel
AutismScreen®
AutismScreen™ is the non-invasive genetic test that screens for autism spectrum disorders in children. The diagnosis of Autism Spectrum Syndromes is not simple and is made only on the basis of behavioral indicators. The AutismScreen ™ test can be a valuable aid for the early identification of a mutation related to a disease. The AutismScreen […]
OncoNext™ Liquid Scan – 50 genes: Analysis of circulating tumor DNA (ctDNA)
OncoNext™ Tissue – 23 genes
OncoNext™ Liquid Scan – 23 genes: Analysis of circulating tumor DNA (ctDNA)
OncoNext™ Liquid Scan – 15 genes: Analysis of circulating tumor DNA (ctDNA)
OncoNext™ Risk – Renal
OncoNext™ Risk Renal is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to the development of Kidney cancer. The test, therefore, allows you to identify patients at risk of developing this neoplasia by analyzing their DNA.
OncoNext™ Risk – Oncoscreening Complete
OncoNext ™ Risk OncoScreening Complete is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to hereditary cancers, including: Breast Cancer, Ovarian / Uterus Cancer, Colorectal Cancer, Stomach Cancer, Pancreatic Cancer, Prostate Cancer, Skin Cancer (Melanoma), Brain Cancer, Kidney Cancer and Pheochromocytoma / Paraganglioma. […]
OncoNext™ Liquid Monitor – Lung: Analysis of circulating tumor DNA (ctDNA)
Eurofins Genoma Group’s OncoNext ™ Liquid genetic tests were designed to study somatic mutations of circulating tumor DNA (ctDNA) in peripheral blood in patients with cancer or at high risk of cancer. The study of ctDNA, also called liquid biopsy, is the most innovative tool that the oncologist can use today. Thanks the OncoNext ™ […]
